XING2DIAGNOSTICS

XING2DIAGNOSTICS develops PETCT-related tracer products in China for the clinical diagnosis of neurodegenerative diseases such as Alzheimer's disease. XING2DIAGNOSTICS has obtained the commercial rights to Eli Lilly's Florbetapir (AV-45), Flortaucipir (AV-1451), and other products in mainland China (excluding Hong Kong, Macao, and Taiwan).